David Holtz, interim president and chief executive officer, and chief financial officer of NUCRYST, said: We are pleased to support Smith Nephew in the European launch of Acticoat Flex. The enhanced conformability of Flex will now be available to European clinicians to simplifying the dressing of wounds on difficult-to-protect articulating regions such as knee or elbow joints while also providing advanced antimicrobial protection.

The CE Mark Certification for Acticoat Flex was received by Smith Nephew last week following the July 510(k) clearance in the US and market approval in Canada late last year.

Roger Teasdale, president of Smith Nephew Wound Management, said: We are delighted that we can now offer our European clinicians this new version of Acticoat. The feedback on Acticoat Flex from the markets where it recently became available has been excellent. We are committed to improving the quality of life of the patients treated with our products like Acticoat Flex, which helps manage the risk of infection in patients with serious wounds.